Interestingly, recent studies determined that the protective TMEM106B variants are associated with reduced levels of TMEM106B [20, 37, 59], suggesting that lowering TMEM106B might be therapeutic in the context of FTD. Here, TMEM106B is linked to frontotemporal dementia.